DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/635ts8/global_renal_dener) has announced the addition of the "Global Renal Denervation Device Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Renal Denervation Device market to grow at a CAGR of 139.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the number of people suffering from hypertension. The Global Renal Denervation Device market has also been witnessing the trend of increasing usage of minimally invasive procedures. However, preference for drug-based therapy to cure hypertension could pose a challenge to the growth of this market.
Key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., ReCor Medical Technology, and St. Jude Medical Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said; The trend of developing medical devices using radiation is being widely adopted by vendors these days. High-frequency radiation is being used in the diagnosis and treatment of several medical conditions such as cancer and hypertension. Further, though the usage of radiation for medical therapy carries high risks, it has been proven to be efficient and safe if used carefully.
According to the report, the increasing number of patients suffering from hypertension increases the demand for Renal Denervation Device procedures, and this is expected to help the Global Renal Denervation Device market to grow significantly by 2015.
Further, the report also discusses that one of the most important challenges in the market is the presence of alternative treatments for curing hypertension.
For more information visit http://www.researchandmarkets.com/research/635ts8/global_renal_dener